<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D567991E-EBD9-43B5-A5F8-6EC90B9CC627"><gtr:id>D567991E-EBD9-43B5-A5F8-6EC90B9CC627</gtr:id><gtr:firstName>Charlene</gtr:firstName><gtr:surname>Fabian</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FB%2F000M0823"><gtr:id>8822179B-F59F-4D0B-BF04-40895820F243</gtr:id><gtr:title>Role of the PI3K Vps34 in T cell immunity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/B/000M0823</gtr:grantReference><gtr:abstractText>Production of pancreatic beta cells is a major objective of regenerative medicine. One promising source of beta cells is through generation from human pluripotent stem cells (hPSC). The non-academic partner of the project, DefiniGEN, are world leaders in producing pancreatic cell types from hPSC. Their technology platform pushes hPSC through sequential cell fate choices that mimic normal developmental processes, ultimately leading to endocrine cells including glucose-responsive insulin-secreting beta cells. Current research challenges include identifying strategies to increase efficiency at each stage of differentiation, and optimise the final steps required to mature the endocrine cells into fully functional hormone-secreting cell types. Trimethylation of histone H3 at lysine 27 (H3K27me3) is catalysed by the Polycomb-protein EZH2, and is associated with the transcriptional repression of genes that encode key developmental regulators. Evidence shows that changes in H3K27me3 are instructive in coordinating cell fate decisions during pancreatic development and beta cell formation in mice. A detailed analysis of the role of EZH2 in human pancreatic development has not been investigated. We will therefore test the hypothesis that EZH2 provides a system of transcriptional repression to control each stage of human pancreatic differentiation. This project will use epigenomic and transcriptomic profiling to define the role of EZH2 in regulating human pancreatic development, and genetic approaches to test whether loss of EZH2 function and associated histone mark at selected stages of differentiation can improve the yield and maturity of beta cell production from hPSC.</gtr:abstractText><gtr:fund><gtr:end>2017-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2016-10-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>12950</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/B/000M0823</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>